Suchergebnisse - "Weisel, Katja C"

PubPharm (59)

1

Genomic Classification and Individualized Prognosis in Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Maura, F. | Rajanna, A. | Ziccheddu, B. | +34

2

BCMA x CD3 T-cell engager in a patient with penta-refractory multiple myeloma and HIV : a clinical and immunological report

enthalten in: Haematologica | 2024

von Cords, L. | Schaefers, C. | Kamili, A. | +9

3

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 2024

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

4

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Leypoldt, L. | Tichy, D. | Besemer, B. | +24

5

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Mai, E. | Goldschmid, H. | Miah, K. | +74

ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740

6

Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment : Results from the Phase 2 GMMG-DANTE Trial

enthalten in: Cancers | 2023

von Leypoldt, L. | Gavriatopoulou, M. | Besemer, B. | +12

7

Management of multiple myeloma-related renal impairment : recommendations from the International Myeloma Working Group

enthalten in: The Lancet. Oncology | 2023

von Dimopoulos, M. | Merlini, G. | Bridoux, F. | +25

8

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Thompson, M. | Boccadoro, M. | Leleu, X. | +26

9

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

enthalten in: Blood cancer journal | 2023

von Mai, E. | Huhn, S. | Miah, K. | +16

10

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Goldschmidt, H. | Mai, E. | Bertsch, U. | +123

CommentIn: Lancet Haematol. 2022 Nov;9(11):e798-e799. - PMID 36328036

1
2
3
4
5
6
Nächster »
[6]